Pfizer: Acquisition spree comparison Two blockbuster-funded deal waves, different playbooks Filed Under: Metabolic disease/endicrinology Brian Buntz As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology
NIDDK describes IBS symptom patterns and triggers
The equal-weighted index and small caps are outperforming again
Not everyone can achieve the 18 waist of an Instagram starlet, but the vast majority of people we meet with are able to enjoy truly amazing results from liposuction
GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues
Deficits exceeding 1,000 kcal daily are generally not recommended outside supervised medical programmes, as they increase risks of nutritional inadequacy, gallstone formation, and loss of lean tissue